• On February 19, 2026, Healthcare Realty Trust’s Audit Committee replaced BDO USA, P.C. with Deloitte & Touche LLP as its independent registered public accounting firm.
• This auditor change follows the company’s recently highlighted stronger balance sheet and detailed 2026 guidance, tightening the focus on financial reporting quality and oversight.
• Next, we’ll examine how the strengthened balance sheet and Deloitte appointment may influence Healthcare Realty Trust’s broader investment narrative.

We've uncovered the 15 dividend fortresses yielding 5%+ that don't just survive market storms, but thrive in them.

Healthcare Realty Trust Investment Narrative Recap

To own Healthcare Realty Trust, you need to believe in steady demand for outpatient medical buildings and the company’s ability to turn today’s under-earning assets into future cash flow. The switch from BDO to Deloitte is a governance and reporting move that does not materially change the near term story, where the key catalyst is operational execution in the lease up portfolio and the biggest risk remains high leverage in a business that is still unprofitable.

The most relevant recent announcement alongside the auditor change is management’s 2026 earnings guidance, which frames expectations around a narrow EPS range between a small loss and a small profit. This low margin starting point sharpens attention on whether the balance sheet improvements and cost efficiencies can actually translate into the targeted NOI uplift, because if operational gains fall short, leverage and interest costs could become more constraining than current guidance implies.

But behind the balance sheet progress, one risk investors should be aware of is that high leverage could still...

Healthcare Realty Trust’s narrative projects $1.2 billion in revenue and $275.4 million in earnings by 2028. This implies a 1.2% yearly revenue decline and an earnings increase of about $683.3 million from -$407.9 million today.

Uncover how Healthcare Realty Trust's forecasts yield a $19.40 fair value, a 4% upside to its current price.

Exploring Other Perspectives

Two fair value estimates from the Simply Wall St Community span roughly US$19.40 to US$28.51 per share, showing how far apart individual views can be. When you compare those opinions with the company’s ongoing leverage and profitability challenges, it underlines why many shareholders look at several different viewpoints before deciding how HR might fit into their portfolio.

Explore 2 other fair value estimates on Healthcare Realty Trust - why the stock might be worth as much as 53% more than the current price!

Reach Your Own Conclusion

Don't just follow the ticker - dig into the data and build a conviction that's truly your own.

• A great starting point for your Healthcare Realty Trust research is our analysis highlighting 1 key reward and 2 important warning signs that could impact your investment decision.
• Our free Healthcare Realty Trust research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Healthcare Realty Trust's overall financial health at a glance.

Ready To Venture Into Other Investment Styles?

Every day counts. These free picks are already gaining attention. See them before the crowd does:

• Outshine the giants: these 21 early-stage AI stocks could fund your retirement.
• Uncover the next big thing with 32 elite penny stocks that balance risk and reward.
• Rare earth metals are an input to most high-tech devices, military and defence systems and electric vehicles. The global race is on to secure supply of these critical minerals. Beat the pack to uncover the 29 best rare earth metal stocks of the very few that mine this essential strategic resource.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.